7Baggers
 how instil bio inc. stock reacts to fed rate cuts - 2025 market trends & daily volume surge signals  The British Mountaineering Council Fri, 26 Sep 2025 03:38:19 GMT
 citizens jmp maintains instil bio(til.us) with hold rating  富途牛牛 Tue, 23 Sep 2025 10:40:19 GMT
 published on: 2025-09-19 05:39:31  newser.com Fri, 19 Sep 2025 10:39:31 GMT
 instil bio executive sells major stock holdings  TipRanks Sat, 13 Sep 2025 04:01:41 GMT
 Instil Bio stock rating reiterated at Buy by H.C. Wainwright  Investing.com Fri, 12 Sep 2025 07:00:00 GMT
 instil bio executive sells major stock holdings  TipRanks Fri, 12 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 22:21:38  Newser Tue, 02 Sep 2025 03:21:38 GMT
 published on: 2025-08-30 20:23:42  Newser Sun, 31 Aug 2025 01:23:42 GMT
 instil bio posts wider loss in q2  AOL.com Sat, 30 Aug 2025 15:34:36 GMT
 published on: 2025-08-29 12:13:27  Newser Fri, 29 Aug 2025 17:13:27 GMT
 published on: 2025-08-28 21:54:34  Newser Fri, 29 Aug 2025 02:54:34 GMT

Instil Bio, Inc.
(NASDAQ:TIL) 

TIL stock logo

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, ...

Founded: 2018
CEO: Bronson Crouch  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends